Research Article
Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients
Table 1
The association between the ZNF667-AS1 expression and different clinicopathological features of 155 human gliomas.
| Parameter | No. of cases | ZNF667-AS1 expression | value | High | Low |
| Age | | | | 0.369 | <50 | 82 | 39 | 43 | | ≥50 | 73 | 40 | 33 | | Gender | | | | 0.394 | Male | 93 | 50 | 43 | | Female | 62 | 29 | 33 | | WHO grade | | | | 0.005 | I-II | 108 | 47 | 61 | | III-IV | 47 | 32 | 15 | | KPS score | | | | 0.008 | <80 | 57 | 37 | 20 | | ≥80 | 98 | 42 | 56 | | Tumor size | | | | 0.145 | <3 cm | 95 | 44 | 51 | | ≥3 cm | 60 | 35 | 25 | |
|
|